奥赛康：10月15日召开董事会会议

Core Viewpoint - Aosaikang (SZ 002755) announced the convening of its seventh fourth board meeting on October 15, 2025, to review documents including the proposal for signing an authorization agreement [1] Company Summary - Aosaikang's revenue composition for the year 2024 is as follows: 97.92% from the pharmaceutical manufacturing industry and 2.08% from other businesses [1]